Max Yield Bio Gene (India)Private Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.70 Cr
- Revenue Growth 346.25%
- Profit Growth 688.05%
- Ebitda 24.68%
- Net Worth 4.61%
- Total Assets -14.03%
About Max Yield Bio Gene (India)Private
Max Yield Bio Gene (India)Private Limited (MYBGIL) is a leading Private Limited Indian Non-Government Company incorporated in India on 09 May 2007 and has a history of 17 years and nine months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹1.70 Cr.
Naga Kota and Sirisha Kota serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01119TG2007PTC053907
-
Company No.
053907
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 May 2007
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Max Yield Bio Gene (India)Private?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sirisha Kota
|
Managing Director | 09-May-2007 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Naga Kota
|
Whole-Time Director | 05-Jan-2011 | Current |
Financial Performance of Max Yield Bio Gene (India)Private.
Max Yield Bio Gene (India)Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 346.25% increase. The company also saw a substantial improvement in profitability, with a 688.05% increase in profit. The company's net worth moved up by a moderate rise of 4.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Max Yield Bio Gene (India)Private?
In 2023, Max Yield Bio Gene (India)Private had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹17.00 M
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 1.20 Cr
- Others : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Aug 2018 | Others | ₹5.00 M | Open |
| 14 Mar 2012 | Punjab National Bank | ₹1.20 Cr | Open |
How Many Employees Work at Max Yield Bio Gene (India)Private?
Unlock and access historical data on people associated with Max Yield Bio Gene (India)Private, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Max Yield Bio Gene (India)Private, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Max Yield Bio Gene (India)Private's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
